Articles with "king kallimanis" as a keyword



Photo from wikipedia

Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials

Sign Up to like & get
recommendations!
Published in 2019 at "Clinical Trials"

DOI: 10.1177/1740774519836989

Abstract: Symptomatic adverse events are common with cancer therapies, and provide key information about tolerability during development and regulatory review. After a therapy becomes available on the market, information about these adverse events is essential for… read more here.

Keywords: information; symptomatic adverse; adverse events; oncology ... See more keywords